Abstract
Abstract
Background
Antibiotic resistance is an ongoing pandemic which represents a global public health threat. To encourage the judicious use of antibiotics, public health discourse and campaigns often engage in threat-based messaging depicting an apocalyptic post-antibiotic future. We studied the effectiveness of the strategy because of mixed evidence for its success, and because it is unclear how experiencing the COVID-19 pandemic might have influenced it.
Methods
We conducted a randomised controlled trial with 378 participants in three waves (before and during the pandemic in 2021 and 2022). Participants were randomly allocated to either the baseline arm, featuring a control film, or the intervention arm featuring a short film, Catch, depicting a post-antibiotic future. Participants expressed expectations and intended requests for antibiotics for a hypothetical ear infection and their adherence to a prescribed antibiotic for a hypothetical kidney infection. In waves 2 and 3, they also reported any COVID-19-related changes to their antibiotic desires.
Results
Showing participants a film about a post-antibiotic future substantially lowers clinically inappropriate expectations for antibiotics and their intended requests. Participants report that the experience of the COVID-19 pandemic decreased their desire for antibiotics but only when they watched the intervention film. The intervention slightly decreases participants’ adherence intentions towards a prescribed antibiotic treatment.
Conclusions
Presenting a film about an apocalyptic post-antibiotic future lowers expectations and intended requests for antibiotics and therefore has the potential to encourage judicious use of them. However, the adverse effects of such messaging on adherence to a course of antibiotics should be proactively managed.
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Mahoney, A. R., Safaee, M. M., Wuest, W. M. & Furst, A. L. The silent pandemic: emergent antibiotic resistances following the global response to SARS-CoV-2. iScience 24, 102304 (2021).
2. Murray, C. J. et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399, 629–655 (2022).
3. Chatterjee, A. et al. Quantifying drivers of antibiotic resistance in humans: a systematic review. Lancet Infect. Dis. 18, e368–e378 (2018).
4. O’Neill, J. Tackling drug-resistant infections globally: final report and recommendations (HM Government and Wellcome Trust, London, 2016).
5. World Health Organization. Global action plan on antimicrobial resistance (WHO Press, World Health Organization, Geneva, Switzerland, 2015).